Please use this identifier to cite or link to this item:https://hdl.handle.net/20.500.12259/34251
Type of publication: Straipsnis Clarivate Analytics Web of Science ar/ir Scopus / Article in Clarivate Analytics Web of Science or / and Scopus (S1)
Field of Science: Biochemija / Biochemistry (N004);Biologija / Biology (N010)
Author(s): Kubiliūtė, Raimonda;Šulskytė, Indrė;Daniūnaitė, Kristina;Daugelavičius, Rimantas;Jarmalaitė, Sonata
Title: Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line
Is part of: Medicina. Kaunas : Lietuvos sveikatos mokslų universitetas, 2016, T. 52, nr. 5
Extent: p. 298-306
Date: 2016
Note: eISSN 1648-9144
Keywords: Žarnyno vėžys;CX-1 ląstelės;Atsparumas doksorubicinui;Epitelinis-mezenchiminis virsmas;Colon cancer CX-1;Doxorubicin resistance;Epithelial-to-mesenchymal transition
Abstract: Background and aim: Resistance to chemotherapy is the key obstacle to the effective treatment of various cancers. Accumulating evidence suggests significant involvement of the epithelial-to-mesenchymal transition (EMT) in the chemoresistance of most cancer types. This study aimed at analyzing the gene expression profile of doxorubicin (DOX)-resistant colorectal cancer cells CX-1. Materials and methods: DOX-resistant CX-1 cell sublines were acquired by stepwise increment of DOX concentrations in cell growth media. Global gene expression profiling was performed using human gene expression microarrays. The expression levels of individual genes were assessed by means of quantitative PCR (qPCR), while the DNA methylation pattern of several selected genes was determined by methylation-specific PCR. Results: Four DOX-resistant CX-1 sublines were established as a valuable tool for cell chemoresistance studies. Altered expression of the EMT, cell adhesion and motility, and chemoresistance-related genes was observed in DOX-resistant cells by genome-wide gene expression analysis. Besides, early and significant upregulation of the key EMT genes ZEB1 (5.8 ; P < 0.001) and CDH2 (6.2 ; P = 0.044) was identified by qPCR, with subsequent activation of drug transporter gene ABCC1 (3.3 ; P = 0.007) and cell stemness gene NANOG (2.4 ; P = 0.008). Downregulation of TET1 (2.1 ; P = 0.041) and changes in the methylation status of the p16 gene were also involved in the acquisition of cell resistance to DOX
Internet: https://doi.org/10.1016/j.medici.2016.09.003
https://doi.org/10.1016/j.medici.2016.09.003
https://eltalpykla.vdu.lt/1/34251
Affiliation(s): Biochemijos katedra
Gamtos mokslų fakultetas
Nacionalinis vėžio institutas
Vilniaus universitetas
Vytauto Didžiojo universitetas
Appears in Collections:1. Straipsniai / Articles
Universiteto mokslo publikacijos / University Research Publications

Files in This Item:
marc.xml11.41 kBXMLView/Open

MARC21 XML metadata

Show full item record

Page view(s)

182
checked on Oct 14, 2019

Download(s)

72
checked on Oct 14, 2019

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons